IL131103A0 - The neurotrophic factor nnt-1 - Google Patents
The neurotrophic factor nnt-1Info
- Publication number
- IL131103A0 IL131103A0 IL13110398A IL13110398A IL131103A0 IL 131103 A0 IL131103 A0 IL 131103A0 IL 13110398 A IL13110398 A IL 13110398A IL 13110398 A IL13110398 A IL 13110398A IL 131103 A0 IL131103 A0 IL 131103A0
- Authority
- IL
- Israel
- Prior art keywords
- nnt
- polypeptides
- neurotrophic factor
- disclosed
- cell
- Prior art date
Links
- 108010025020 Nerve Growth Factor Proteins 0.000 title abstract 2
- 102000007072 Nerve Growth Factors Human genes 0.000 title abstract 2
- 239000003900 neurotrophic factor Substances 0.000 title abstract 2
- 101100011077 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) nnt-1 gene Proteins 0.000 title 1
- 102100029391 Cardiotrophin-like cytokine factor 1 Human genes 0.000 abstract 3
- 101710107109 Cardiotrophin-like cytokine factor 1 Proteins 0.000 abstract 3
- 229920001184 polypeptide Polymers 0.000 abstract 3
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 3
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 3
- 210000001744 T-lymphocyte Anatomy 0.000 abstract 1
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 1
- 210000003719 b-lymphocyte Anatomy 0.000 abstract 1
- 230000028709 inflammatory response Effects 0.000 abstract 1
- 102000039446 nucleic acids Human genes 0.000 abstract 1
- 108020004707 nucleic acids Proteins 0.000 abstract 1
- 150000007523 nucleic acids Chemical class 0.000 abstract 1
- 230000004936 stimulating effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Rheumatology (AREA)
- Biochemistry (AREA)
- Pain & Pain Management (AREA)
- Immunology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Psychology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IL15454198A IL154541A0 (en) | 1997-02-03 | 1998-02-02 | The neurotrophic factor nnt-1 |
| IL15454298A IL154542A0 (en) | 1997-02-03 | 1998-02-02 | The neurotrophic factor nnt-1 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/792,019 US5741772A (en) | 1997-02-03 | 1997-02-03 | Neurotrophic factor NNT-1 |
| US09/016,534 US6143874A (en) | 1997-02-03 | 1998-01-30 | Antibodies to the neurotrophic factor NNT-1 |
| PCT/US1998/002363 WO1998033922A1 (en) | 1997-02-03 | 1998-02-02 | The neurotrophic factor nnt-1 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL131103A0 true IL131103A0 (en) | 2001-01-28 |
Family
ID=26688735
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL15454398A IL154543A0 (en) | 1997-02-03 | 1998-02-02 | The neurotrophic factor nnt-1 |
| IL13110398A IL131103A0 (en) | 1997-02-03 | 1998-02-02 | The neurotrophic factor nnt-1 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL15454398A IL154543A0 (en) | 1997-02-03 | 1998-02-02 | The neurotrophic factor nnt-1 |
Country Status (14)
| Country | Link |
|---|---|
| EP (1) | EP0977859B1 (zh) |
| JP (1) | JP2002514067A (zh) |
| CN (1) | CN1195853C (zh) |
| AT (1) | ATE273391T1 (zh) |
| AU (1) | AU718882B2 (zh) |
| CA (1) | CA2279999C (zh) |
| DE (1) | DE69825580T2 (zh) |
| DK (1) | DK0977859T3 (zh) |
| ES (1) | ES2226097T3 (zh) |
| HK (1) | HK1025125A1 (zh) |
| HU (1) | HU225307B1 (zh) |
| IL (2) | IL154543A0 (zh) |
| PT (1) | PT977859E (zh) |
| WO (1) | WO1998033922A1 (zh) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU8165298A (en) * | 1997-06-30 | 1999-01-19 | Human Genome Sciences, Inc. | Cardiotrophin-like cytokine |
| US6800460B1 (en) | 1999-03-11 | 2004-10-05 | Schering Corporation | Mammalian cytokine complexes |
| ATE420894T1 (de) * | 1999-03-11 | 2009-01-15 | Schering Corp | Cytokine aus säugetieren, verwandte reagenzien und verfahren |
| FR2804436B1 (fr) * | 2000-01-27 | 2002-08-02 | Pf Medicament | PROTEINE DE FUSION scsCNTFR/NNT-1 |
| FR2804435A1 (fr) * | 2000-01-27 | 2001-08-03 | Pf Medicament | COMPLEXE ISOLE COMPRENANT UNE PROTEINE NNT-1 ET EN OUTRE AU MOINS UNE PROTEINE CLF-1 ET/OU UNE PROTEINE sCNTFRalpha |
| FR2804434A1 (fr) * | 2000-01-27 | 2001-08-03 | Pf Medicament | Heterocomplexe nnt-1/clf-1 et son utilisation en tant qu'activateur du recepteur complexe cntrfalpha/gp130/lifrbet a |
| US6849260B2 (en) * | 2000-08-18 | 2005-02-01 | Amgen Inc. | Methods and compositions for treating IgE-related disease using NNT-1 inhibitors |
-
1998
- 1998-02-02 CN CNB988036428A patent/CN1195853C/zh not_active Expired - Fee Related
- 1998-02-02 ES ES98906215T patent/ES2226097T3/es not_active Expired - Lifetime
- 1998-02-02 CA CA002279999A patent/CA2279999C/en not_active Expired - Fee Related
- 1998-02-02 WO PCT/US1998/002363 patent/WO1998033922A1/en active IP Right Grant
- 1998-02-02 AT AT98906215T patent/ATE273391T1/de not_active IP Right Cessation
- 1998-02-02 IL IL15454398A patent/IL154543A0/xx active IP Right Grant
- 1998-02-02 DK DK98906215T patent/DK0977859T3/da active
- 1998-02-02 HU HU0001969A patent/HU225307B1/hu not_active IP Right Cessation
- 1998-02-02 IL IL13110398A patent/IL131103A0/xx not_active IP Right Cessation
- 1998-02-02 JP JP53325898A patent/JP2002514067A/ja active Pending
- 1998-02-02 AU AU61495/98A patent/AU718882B2/en not_active Ceased
- 1998-02-02 EP EP98906215A patent/EP0977859B1/en not_active Expired - Lifetime
- 1998-02-02 DE DE69825580T patent/DE69825580T2/de not_active Expired - Fee Related
- 1998-02-02 PT PT98906215T patent/PT977859E/pt unknown
-
2000
- 2000-06-01 HK HK00103324A patent/HK1025125A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| CA2279999A1 (en) | 1998-08-06 |
| DE69825580T2 (de) | 2005-09-29 |
| EP0977859B1 (en) | 2004-08-11 |
| EP0977859A1 (en) | 2000-02-09 |
| ATE273391T1 (de) | 2004-08-15 |
| IL154543A0 (en) | 2003-09-17 |
| HK1025125A1 (en) | 2000-11-03 |
| DE69825580D1 (de) | 2004-09-16 |
| CN1251134A (zh) | 2000-04-19 |
| HUP0001969A2 (hu) | 2000-10-28 |
| HU225307B1 (en) | 2006-09-28 |
| DK0977859T3 (da) | 2004-12-06 |
| AU6149598A (en) | 1998-08-25 |
| CA2279999C (en) | 2004-07-27 |
| JP2002514067A (ja) | 2002-05-14 |
| AU718882B2 (en) | 2000-04-20 |
| WO1998033922A1 (en) | 1998-08-06 |
| CN1195853C (zh) | 2005-04-06 |
| PT977859E (pt) | 2004-12-31 |
| HUP0001969A3 (en) | 2002-01-28 |
| ES2226097T3 (es) | 2005-03-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2267668A1 (en) | Method for enhancing the efficiency of gene transfer with stem cell factor polypeptide | |
| HUP0000317A3 (en) | Process for the preparation of recombinant proteins in e.coli by high cell density fermentation | |
| AU3246300A (en) | Polypeptides having galactose oxidase activity and nucleic acids encoding same | |
| SI0917571T1 (en) | Agouti-related gene | |
| AU7165287A (en) | DNA encoding streptavidin, streptavidin produced therefrom, fused polypeptides which include amino acid sequences present in streptavidin and uses thereof | |
| WO2000075350A3 (en) | Nucleic acid sequences encoding proteins involved in fatty acid beta-oxidation and methods of use | |
| CA2315274A1 (en) | Polypeptides having aminopeptidase activity and nucleic acids encoding same | |
| ZA967173B (en) | Purified coprinus laccases and nucleic acids and encoding same | |
| CA2263889A1 (en) | P-selectin ligand proteins | |
| WO2001029222A3 (en) | Polypeptides having phospholipase b activity and nucleic acids encoding same | |
| DE69930955D1 (de) | Polypeptide mit lysophospholipaseaktivität und nukleinesäuren die sie kodieren | |
| AU7381098A (en) | Polypeptides having prolyl pipeptidyl aminopeptidase activity and nucleic acids encoding same | |
| EP0182372A3 (en) | New factor viii coagulant polypeptides | |
| WO1998021343A8 (en) | Genes encoding telomerase proteins | |
| AU3802595A (en) | Tripeptidyl aminopeptidase | |
| AU7489098A (en) | Polypeptides having aminopeptidase activity and nucleic acids encoding same | |
| CA2306449A1 (en) | Rapid generation of stable mammalian cell lines producing high levels of recombinant proteins | |
| AU2658200A (en) | Oxaloacetate hydrolase deficient fungal host cells | |
| IL154543A0 (en) | The neurotrophic factor nnt-1 | |
| WO2000028043A3 (en) | Polypeptides having lactonohydrolase activity and nucleic acids encoding same | |
| AU5727099A (en) | A 2,6-beta-d-fructan hydrolase enzyme and processes for using the enzyme | |
| AU2001238064A1 (en) | 18477, a human protein kinase and uses therefor | |
| WO2000041509A3 (en) | Polypeptides having acid phosphatase activity and nucleic acids encoding same | |
| DK0919621T3 (da) | Human TAK1 og DNA der koder derfor | |
| ATE288491T1 (de) | Polypeptide mit 5-aminolevulinsäure synthaseaktivität und deren nukleinsäuren |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FF | Patent granted | ||
| KB | Patent renewed | ||
| MM9K | Patent not in force due to non-payment of renewal fees |